Eva Prieschl-Grassauer
Founder presso MARINOMED BIOTECH AG
Profilo
Eva Prieschl-Grassauer is the founder and Chief Scientific Officer at Marinomed Biotech AG, which is founded in 2006.
She previously worked as Head-Laboratory at AUSTRIANOVA Biomanufacturing AG from 2002 to 2006, and as Head-Allergy Program at Novartis Austria GmbH.
She also worked as a Product Manager at Wyeth Pharmaceuticals BV in 2002 and as a Project Manager at Onepharma in 2006.
Dr. Prieschl-Grassauer holds a doctorate degree from the University of Vienna.
Posizioni attive di Eva Prieschl-Grassauer
Società | Posizione | Inizio |
---|---|---|
MARINOMED BIOTECH AG | Founder | 01/01/2006 |
Precedenti posizioni note di Eva Prieschl-Grassauer
Società | Posizione | Fine |
---|---|---|
Onepharma | Corporate Officer/Principal | 01/07/2006 |
AUSTRIANOVA Biomanufacturing AG
AUSTRIANOVA Biomanufacturing AG BiotechnologyHealth Technology AUSTRIANOVA Biomanufacturing AG engages in the developmente of proprietary drug delivery technologies in orphan niche indications in oncology. It offers NovaCaps, which targets tumours in pancreatic cancer. The company was founded in 2001 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | 01/01/2006 |
Wyeth Pharmaceuticals BV | Corporate Officer/Principal | 01/10/2002 |
Novartis Austria GmbH
Novartis Austria GmbH Pharmaceuticals: MajorHealth Technology Novartis Austria GmbH operates as a holding company, which engages in the development and production of pharmaceutical products. The company was founded on January 30, 2006 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | - |
Formazione di Eva Prieschl-Grassauer
University of Vienna | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MARINOMED BIOTECH AG | Health Technology |
Aziende private | 4 |
---|---|
AUSTRIANOVA Biomanufacturing AG
AUSTRIANOVA Biomanufacturing AG BiotechnologyHealth Technology AUSTRIANOVA Biomanufacturing AG engages in the developmente of proprietary drug delivery technologies in orphan niche indications in oncology. It offers NovaCaps, which targets tumours in pancreatic cancer. The company was founded in 2001 and is headquartered in Vienna, Austria. | Health Technology |
Novartis Austria GmbH
Novartis Austria GmbH Pharmaceuticals: MajorHealth Technology Novartis Austria GmbH operates as a holding company, which engages in the development and production of pharmaceutical products. The company was founded on January 30, 2006 and is headquartered in Vienna, Austria. | Health Technology |
Wyeth Pharmaceuticals BV | |
Onepharma |
- Borsa valori
- Insiders
- Eva Prieschl-Grassauer